Literature DB >> 9535418

Time-voltage QRS area of the 12-lead electrocardiogram: detection of left ventricular hypertrophy.

P M Okin1, M J Roman, R B Devereux, T G Pickering, J S Borer, P Kligfield.   

Abstract

Identification of left ventricular hypertrophy (LVH) using 12-lead ECG criteria based primarily on QRS amplitudes has been limited by poor sensitivity at acceptable levels of specificity. Because the product of QRS voltage and duration, as an approximation of the time-voltage area of the QRS complex, can improve accuracy of the 12-lead ECG for LVH, we examined the diagnostic value of true time-voltage area measurements of QRS complexes from the standard 12-lead ECG. Standard 12-lead ECGs and echocardiograms were obtained in 175 control subjects without LVH and in 74 patients with regurgitant valvular heart disease and LVH defined by echocardiographic criteria (indexed LV mass >110 g/m2 in women and >125 g/m2 in men). Standard voltage criteria, voltage-duration products (voltage multiplied by QRS duration), and true time-voltage areas of the QRS were calculated for Sokolow-Lyon criteria (SV1 +RV(5/6)) and the 12-lead sum of voltage criteria. Test sensitivities were compared using gender-specific partitions with matched specificity of 98% in the 175 subjects without LVH. Measurement of the time-voltage area significantly improved sensitivity for both criteria. The 76% sensitivity of the 12-lead sum area and 65% sensitivity of Sokolow-Lyon area were significantly greater than the 54% sensitivity of the approximation of QRS area provided by each voltage-duration product (P<.001 and P=.021) and than the 46% and 43% sensitivities of the respective simple voltage criteria (each P<.001). Comparison of receiver operating characteristic curves confirmed the superior overall performance of time-voltage area criteria compared with both voltage-duration products and simple voltage criteria. These results suggest that use of time-voltage areas can dramatically improve identification of LVH by 12-lead ECG. Further study of this approach is needed to identify optimal criteria for LVH based on the time-voltage area measurements from the 12-lead ECG.

Entities:  

Mesh:

Year:  1998        PMID: 9535418     DOI: 10.1161/01.hyp.31.4.937

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  16 in total

1.  52 Genetic Loci Influencing Myocardial Mass.

Authors:  Pim van der Harst; Jessica van Setten; Niek Verweij; Georg Vogler; Lude Franke; Matthew T Maurano; Xinchen Wang; Irene Mateo Leach; Mark Eijgelsheim; Nona Sotoodehnia; Caroline Hayward; Rossella Sorice; Osorio Meirelles; Leo-Pekka Lyytikäinen; Ozren Polašek; Toshiko Tanaka; Dan E Arking; Sheila Ulivi; Stella Trompet; Martina Müller-Nurasyid; Albert V Smith; Marcus Dörr; Kathleen F Kerr; Jared W Magnani; Fabiola Del Greco M; Weihua Zhang; Ilja M Nolte; Claudia T Silva; Sandosh Padmanabhan; Vinicius Tragante; Tõnu Esko; Gonçalo R Abecasis; Michiel E Adriaens; Karl Andersen; Phil Barnett; Joshua C Bis; Rolf Bodmer; Brendan M Buckley; Harry Campbell; Megan V Cannon; Aravinda Chakravarti; Lin Y Chen; Alessandro Delitala; Richard B Devereux; Pieter A Doevendans; Anna F Dominiczak; Luigi Ferrucci; Ian Ford; Christian Gieger; Tamara B Harris; Eric Haugen; Matthias Heinig; Dena G Hernandez; Hans L Hillege; Joel N Hirschhorn; Albert Hofman; Norbert Hubner; Shih-Jen Hwang; Annamaria Iorio; Mika Kähönen; Manolis Kellis; Ivana Kolcic; Ishminder K Kooner; Jaspal S Kooner; Jan A Kors; Edward G Lakatta; Kasper Lage; Lenore J Launer; Daniel Levy; Alicia Lundby; Peter W Macfarlane; Dalit May; Thomas Meitinger; Andres Metspalu; Stefania Nappo; Silvia Naitza; Shane Neph; Alex S Nord; Teresa Nutile; Peter M Okin; Jesper V Olsen; Ben A Oostra; Josef M Penninger; Len A Pennacchio; Tune H Pers; Siegfried Perz; Annette Peters; Yigal M Pinto; Arne Pfeufer; Maria Grazia Pilia; Peter P Pramstaller; Bram P Prins; Olli T Raitakari; Soumya Raychaudhuri; Ken M Rice; Elizabeth J Rossin; Jerome I Rotter; Sebastian Schafer; David Schlessinger; Carsten O Schmidt; Jobanpreet Sehmi; Herman H W Silljé; Gianfranco Sinagra; Moritz F Sinner; Kamil Slowikowski; Elsayed Z Soliman; Timothy D Spector; Wilko Spiering; John A Stamatoyannopoulos; Ronald P Stolk; Konstantin Strauch; Sian-Tsung Tan; Kirill V Tarasov; Bosco Trinh; Andre G Uitterlinden; Malou van den Boogaard; Cornelia M van Duijn; Wiek H van Gilst; Jorma S Viikari; Peter M Visscher; Veronique Vitart; Uwe Völker; Melanie Waldenberger; Christian X Weichenberger; Harm-Jan Westra; Cisca Wijmenga; Bruce H Wolffenbuttel; Jian Yang; Connie R Bezzina; Patricia B Munroe; Harold Snieder; Alan F Wright; Igor Rudan; Laurie A Boyer; Folkert W Asselbergs; Dirk J van Veldhuisen; Bruno H Stricker; Bruce M Psaty; Marina Ciullo; Serena Sanna; Terho Lehtimäki; James F Wilson; Stefania Bandinelli; Alvaro Alonso; Paolo Gasparini; J Wouter Jukema; Stefan Kääb; Vilmundur Gudnason; Stephan B Felix; Susan R Heckbert; Rudolf A de Boer; Christopher Newton-Cheh; Andrew A Hicks; John C Chambers; Yalda Jamshidi; Axel Visel; Vincent M Christoffels; Aaron Isaacs; Nilesh J Samani; Paul I W de Bakker
Journal:  J Am Coll Cardiol       Date:  2016-09-27       Impact factor: 24.094

2.  Gender differences in the diagnosis and treatment of left ventricular hypertrophy detected by different electrocardiographic criteria. Findings from the SARA study.

Authors:  Vivencio Barrios; Carlos Escobar; Alberto Calderón; Sara Barrios; Josefa Navarro-Cid; Elena Ferrer; Rocio Echarri
Journal:  Heart Vessels       Date:  2010-01-21       Impact factor: 2.037

3.  Electrocardiographic criteria for left ventricular hypertrophy in children.

Authors:  Peter R Rijnbeek; Gerard van Herpen; Livia Kapusta; A Derk Jan Ten Harkel; Maarten Witsenburg; Jan A Kors
Journal:  Pediatr Cardiol       Date:  2008-04-25       Impact factor: 1.655

4.  Integrative Functional Annotation of 52 Genetic Loci Influencing Myocardial Mass Identifies Candidate Regulatory Variants and Target Genes.

Authors:  Daiane Hemerich; Jiayi Pei; Magdalena Harakalova; Jessica van Setten; Sander Boymans; Bas J Boukens; Igor R Efimov; Michelle Michels; Jolanda van der Velden; Aryan Vink; Caroline Cheng; Pim van der Harst; Jason H Moore; Michal Mokry; Vinicius Tragante; Folkert W Asselbergs
Journal:  Circ Genom Precis Med       Date:  2019-02

5.  Correlation relationship assessment between left ventricular hypertrophy voltage criteria and body mass index in 41,806 Swiss conscripts.

Authors:  Roger Abächerli; Lingchuan Zhou; Johann-Jakob Schmid; Richard Kobza; Bernhard Niggli; Franz Frey; Paul Erne
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-10       Impact factor: 1.468

6.  Left ventricular hypertrophy and chronic fluid overload in peritoneal dialysis patients.

Authors:  Rizna Abdul Cader; Osama Ali Ibrahim; Samir Paul; Halim Abdul Gafor; Rozita Mohd
Journal:  Int Urol Nephrol       Date:  2013-12-05       Impact factor: 2.370

7.  Q wave area for stratification of global left ventricular infarct size: comparison to conventional ECG assessment using Selvester QRS-score.

Authors:  Jonathan W Weinsaft; Jonathan D Kochav; Anika Afroz; Peter M Okin
Journal:  Coron Artery Dis       Date:  2014-03       Impact factor: 1.439

8.  P wave area for quantitative electrocardiographic assessment of left atrial remodeling.

Authors:  Jonathan W Weinsaft; Jonathan D Kochav; Jiwon Kim; Sergey Gurevich; Samuel C Volo; Anika Afroz; Maya Petashnick; Agnes Kim; Richard B Devereux; Peter M Okin
Journal:  PLoS One       Date:  2014-06-05       Impact factor: 3.240

9.  Electrocardiographic left ventricular hypertrophy regression induced by an angiotensin receptor blocker-based regimen in hypertensive patients with the metabolic syndrome: data from the SARA Study.

Authors:  Carlos Escobar; Vivencio Barrios; Alberto Calderón; Sara Barrios; Rocio Echarri; Josefa Navarro-Cid; Elena Ferrer; Raúl Fernandez
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-03       Impact factor: 3.738

Review 10.  Mechanism of angiotensin II type 1 receptor blocker action in the regression of left ventricular hypertrophy.

Authors:  Sverre E Kjeldsen; Arne Strand; Stevo Julius; Peter M Okin
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-07       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.